CPHA Canvax

"Given multiple studies have demonstrated a rare risk for developing myocarditis and/or pericarditis after receiving mRNA COVID-19 vaccines, this guide provides clinicians with recommendations on how to recognize and address potential cases of myocarditis and/or pericarditis." - Clinical Considerations: Myocarditis and Pericarditis after Receipt of mRNA COVID-19 Vaccines Among Adolescents and Young Adults

Rating See Comments Ratings

Category:

Vaccine Safety and Development,Program Planning and Delivery,Vaccine Safety,Program Delivery and Evaluation,Adverse Events Following Immunization (AEFI),Clinics,Monitoring and Surveillance,Outbreaks and Pandemics,COVID-19 Vaccine Safety and Development
Program Planning and Delivery
Vaccine Safety
Program Delivery and Evaluation
Adverse Events Following Immunization (AEFI)
Clinics
Monitoring and Surveillance
Outbreaks and Pandemics
COVID-19

0 Comments

Using the comment box below, provide your feedback for this resource. Tell the immunization community how you used the resource, what worked, what didn't and the changes you made. The feedback provided will help inform the immunization community and improve upon the resource made available on CANVax.

All comments are anonymous. Submitted comments will be reviewed for approval by the CANVax team to ensure it meets content submission guidelines. Please note that although CANVax aims to approve comments in a timely manner, volume may result in delays.